在治疗头癌的辐射过程中使用西斯普拉丁:NRG瘤学经验的见解
Luana G Sousa1, James Edward Bates2, Payal Anand3
1Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Journal of the National Cancer Institute
|December 4, 2025
概括
这一共识为在头癌化学辐射中施用西斯的实用指导提供了指导,旨在标准化方案,降低毒性,改善患者在治疗和短缺期间的治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 临床药理学 临床药理学
背景情况:
- 西斯普拉丁是用于头癌的关键放射敏感剂.
- 目前西斯普拉丁的使用在临床实践和试验中缺乏标准化.
研究的目的:
- 为在头癌的放射治疗期间提供关于西斯丁的实用指导.
- 解决在临床实践和试验中使用西斯的非标准化方面.
主要方法:
- 来自NRG头部和部瘤学工作组的共识建议.
- 对临床试验协议,回顾性/前性数据和专家共识的审查.
- 专注于时间,前期治疗,补水,耳毒性监测和缺乏管理.
主要成果:
- 关于西斯普拉丁给药时间,支持性护理和毒性管理的建议建议.
- 概述了管理思柏短缺的策略.
- 强调对试验积累和患者结果的协议灵活性.
结论:
- 一个统一的框架,以优化 Cisplatin 在头部和部癌症的化学辐射中的使用.
- 旨在改善粘附性,降低毒性,并保持瘤疗效.
- 建议为未来的试验设计和临床实践指南提供信息,以提供公平的护理.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...